Stock Report

All about this stock under one free report Last Updated: 17-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Homology Medicines Inc. (FIXX)

Stock Card factsheet share-fund-plan-icon

$0.89

up-down-arrow $-15.80 (-94.66%)

As on 25-Mar-2024 18:27EDT

Market cap

info icon

$3 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Homology Medicines (FIXX) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: -- High: --

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-64 Mln

  • ROEROE information

    -0.9 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    0.9

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $1.3

  • EPSEPS information

    $-1.9

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    3,229,640

8 Years Aggregate

CFO

$-549.90 Mln

EBITDA

$-767.29 Mln

Net Profit

$-528.32 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Homology Medicines (FIXX)
-83.7 -88.5 -82.6 -89.1 -78.1 -67.1 --
BSE Sensex*
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 25-Mar-2024  |  *As on 15-May-2026  |  #As on 26-Oct-2023
Company
2023
2022
2021
2020
2019
Homology Medicines (FIXX)
-51.7 -65.4 -67.8 -45.5 -7.4
S&P Small-Cap 600
13.9 -17.4 25.3 9.6 20.9
BSE Sensex
18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Homology Medicines (FIXX)
0.9 3.0 1.2 -113.0 -7,739.1 -90 -- 0.0
Graphite Bio Inc (GRPH)
22.3 185.2 0.0 -124.7 -494.4 -52 -- 1.0

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Homology Medicines (FIXX)

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic...  stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.  Read more

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Homology Medicines (FIXX)

The share price of Homology Medicines Inc (FIXX) is $0.89 (NASDAQ) as of 25-Mar-2024 18:27 EDT. Homology Medicines Inc (FIXX) has given a return of -78.07% in the last 3 years.

Since, TTM earnings of Homology Medicines Inc (FIXX) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2023
-0.31
0.48
2022
149.96
0.41
2021
-2.17
1.23
2020
-4.02
2.61
2019
-9.55
3.62

The 52-week high and low of Homology Medicines Inc (FIXX) are Rs -- and Rs -- as of 17-May-2026.

Homology Medicines Inc (FIXX) has a market capitalisation of $ 3 Mln as on 05-Apr-2024. As per SEBI classification, it is a Small Cap company.

Before investing in Homology Medicines Inc (FIXX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.